Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial
Joon Young Song, Hee Jin Cheong, Jacob Lee, Heung Jeong Woo, Seong Heon Wie, Jin Soo Lee, Shin Woo Kim, Ji Yun Noh, Won Suk Choi, Hun Kim, Kyung Ho Kim, Woo Joo Kim
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial'. Together they form a unique fingerprint.